Page 78 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019 SOCIEDAD ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
Pósteres en congresos internacionales
• De La Fuente A, Beneit P, Muñoz Gama A, et al. Decitabine as Salvage Therapy after Azacitidine in AML. Ann Hematol. 2019;98(Suppl. 1):S45-S46. Abstract: 47.
• Sargas C, Ayala R, Chillón C, et al. Multicentre Implementation of Next Genera- tion Sequencing to Acute Myeloid Leukemia Patients in PETHEMA Spanish Col- laborative Group. Ann Hematol. 2019;98(Suppl. 1):S38-S39. Abstract: 38.
• Sitges M, Boluda B, Garrido A, et al. Outcome of Acute Myeloid Leukemia with Inv(3)(q21q26.2)/ T(3;3)(Q21;Q26.2). Experience of the Spanish PETHEMA and CETLAM Groups. Ann Hematol. 2019;98(Suppl. 1):S42-S42. Abstract: 42.
• Jabbour E, Martinelli G, Vignetti M, Ribera JM, Gómez-Almaguer D, Minami Y, Xu J, Srivastava S, Neumann F, Kantarjian HM. Phase 3 PhALLCON study: Ponatinib (PON) versus imatinib (IM) with reduced-intensity chemotherapy (CT) in patients (pts) with newly diagnosed Philadelphia chromosome positive (Phplus ) ALL. An- nual Meeting of the American Society of Clinical Oncology (ASCO). Chicago, IL, May 31-Jun 04, 2019. J Clin Oncol. 2019;37(15 Suppl). Abstract: TPS7061.
• Durie BG, Goldschmidt H, Mateos MV, González V, Du J, Kim K, Merlini G, Mangiaca- valli S, Min CK, Dimopoulos MA, Kastritis E, Ludwig H, Esteves G, Handa H, Escalante F, Fernández de Larrea Rodríguez C, Delforge M, Cameron C, Vincent Rajkumar S, Kumar S. Outcomes of patients with t(11;14) multiple myeloma: an International Myeloma Working Group (IMWG) multicenter study. Annual Meeting of the ASCO. Chicago, IL, May 31-Jun 04, 2019. J Clin Oncol. 2019;37(15 Suppl). Abstract: 8015.
• Ribera JM, García-Calduch O, Gil C, González-Campos J, Moreno MJ, Barba P, Amigo ML, Martínez-Carballeira D, Alonso N, Bergua J, Mercadal S, Cladera A, Vall- Llovera F, García-Guiñón A, López A, Lavilla E, Sierra M, Hernández-Rivas JM; on behalf of the PETHEMA Group. Clinicobiologic characteristics and outcome of elderly frail patients with acute lymphoblastic leukemia included in a specific protocol (ALL-07FRAIL). 24th Congress of the European-Hematology-Association (EHA). Amsterdam, Jun 13-16, 2019. EHA Library. María Ribera J. 06/14/19; 265972; PF182.
• De La Fuente A, Tormo M, Beneit P, Gil C, Bernal Castillo T, Serrano López J, Javier González K, Sampol Mayol A, Dávila Valls J, Martínez Chamorro C, Suárez Ordóñez S, Benavente C, Bergua J, Jiménez Bravo de Laguna S, Espadana A, Martínez Sánchez
78